Edgestream Partners, L.P. Bridge Bio Pharma, Inc. Transaction History

Edgestream Partners, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$27.35 - $40.45 $196,564 - $290,714	-7,187 Reduced 14.29%	43,115 $1.33 Million
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $846,993 - $1.55 Million	35,262 Added 234.45%	50,302 $2.03 Million
Q3 2023 Nov 14, 2023	BUY	$16.89 - $35.01 $10,100 - $20,935	598 Added 4.14%	15,040 $396,000
Q2 2023 Aug 10, 2023	BUY	$13.29 - $18.01 $191,934 - $260,100	14,442 New	14,442 $248,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.92B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Edgestream Partners, L.P. with notifications on news.